SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Clown-Free Zone... sorry, no clowns allowed

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: patron_anejo_por_favor who wrote (104980)5/25/2001 11:30:45 PM
From: Ilaine  Read Replies (1) of 436258
 
Gleevec, aka glivec, is Novartis' new baby for CML - very effective on chronic myelogenous leukemia and now undergoing clinical trials for a number of other tumors, e.g., prostate cancer, glioma - very promising, and has been fast-tracked.

newcmldrug.com

Novartis has an official site, but it seems to be screwed up:

gleevec.com

Someone who has posted on this thread from time to time - not one of the regulars - is undergoing clinical trials with Gleevec and my prayers are with him. My father's third wife died of glioma a couple of years ago - there was no real cure then. So my fingers are crossed.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext